Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultimate Low Grade Glioma Study
NCT00003015Phase 3Unknown
- Sponsor
- SIOP
- Start
- Jan 1997
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of carboplatin, vincristine in low-grade glioma (LGG), sponsored by SIOP. Status: unknown.
02
Drugs
carboplatinvincristine
03
Conditions
low-grade glioma (LGG)
Beyond the preview
Go deeper on NCT00003015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003015.